Fongsaran Chanida, Jirakanwisal Krit, Peng Bi-Hung, Fracassi Anna, Taglialatela Giulio, Dineley Kelly T, Paessler Slobodan, Cisneros Irma E
Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.
Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.
Brain Behav Immun Health. 2024 Apr 24;38:100780. doi: 10.1016/j.bbih.2024.100780. eCollection 2024 Jul.
Alzheimer's disease is classified as a progressive disorder resulting from protein misfolding, also known as proteinopathies. Proteinopathies include synucleinopathies triggered by misfolded amyloid α-synuclein, tauopathies triggered by misfolded tau, and amyloidopathies triggered by misfolded amyloid of which Alzheimer's disease (β-amyloid) is most prevalent. Most neurodegenerative diseases (>90%) are not due to dominantly inherited genetic causes. Instead, it is thought that the risk for disease is a complicated interaction between inherited and environmental risk factors that, with age, drive pathology that ultimately results in neurodegeneration and disease onset. Since it is increasingly appreciated that encephalitic viral infections can have profoundly detrimental neurological consequences long after the acute infection has resolved, we tested the hypothesis that viral encephalitis exacerbates the pathological profile of protein-misfolding diseases. Using a robust, reproducible, and well-characterized mouse model for β-amyloidosis, Tg2576, we studied the contribution of alphavirus-induced encephalitis (TC-83 strain of VEEV to model alphavirus encephalitis viruses) on the progression of neurodegenerative pathology. We longitudinally evaluated neurological, neurobehavioral, and cognitive levels, followed by a post-mortem analysis of brain pathology focusing on neuroinflammation. We found more severe cognitive deficits and brain pathology in Tg2576 mice inoculated with TC-83 than in their mock controls. These data set the groundwork to investigate sporadic Alzheimer's disease and treatment interventions for this infectious disease risk factor.
阿尔茨海默病被归类为一种由蛋白质错误折叠引起的进行性疾病,也称为蛋白病。蛋白病包括由错误折叠的淀粉样α-突触核蛋白引发的突触核蛋白病、由错误折叠的tau蛋白引发的tau蛋白病,以及由错误折叠的淀粉样蛋白引发的淀粉样蛋白病,其中阿尔茨海默病(β-淀粉样蛋白)最为常见。大多数神经退行性疾病(>90%)并非由显性遗传基因原因导致。相反,人们认为疾病风险是遗传和环境风险因素之间复杂的相互作用,随着年龄增长,这种相互作用会推动病理过程,最终导致神经退行性变和疾病发作。由于人们越来越认识到脑炎病毒感染在急性感染消退后很长时间仍可能产生严重有害的神经后果,我们检验了病毒脑炎会加剧蛋白质错误折叠疾病病理特征的假设。我们使用一种强大、可重复且特征明确的β-淀粉样变性小鼠模型Tg2576,研究了甲病毒诱导的脑炎(委内瑞拉马脑炎病毒TC-83株,用于模拟甲病毒脑炎病毒)对神经退行性病理进展的影响。我们纵向评估了神经、神经行为和认知水平,随后对脑病理进行了尸检分析,重点关注神经炎症。我们发现,接种TC-83的Tg2576小鼠比其假手术对照组出现了更严重的认知缺陷和脑病理变化。这些数据为研究散发性阿尔茨海默病以及针对这种传染病风险因素的治疗干预奠定了基础。